Thomson Reuters

The Investigational Drugs database (IDdb) is a daily-updated, competitive intelligence and R&D monitoring service for the pharmaceutical, biotechnology, and chemical industries.

Through IDdb, you can use powerful search functionality to gather essential scientific and commercial information about investigational drugs at all stages of the R&D pipeline, from first patent to launch or discontinuation.

The database includes information on more than 25,000 investigational drugs and contains nearly 500,000 references. Periodically, new data that has been added to IDdb is sent to an outside expert, from our pool of more than 2,000 senior scientists, for further analysis and evaluation. Our experts upgrade the data into competitor intelligence.

The premier pharmaceutical competitor intelligence service.

With IDdb, you can:

• Locate relevant information quickly and easily via powerful search and browse tools.
• Set up personalized alerts (daily, weekly or monthly) to keep up to date with developments in your field.
• Track the research activities of your competitors.
• Monitor the daily news in specific areas of interest.
• Learn early about advances in research programs.
• Hear vital disclosures from meeting reports first.
• Get timely information on licensing opportunities.
  

Why choose IDdb?

• Company communications: annual reports, press releases, and regulatory documents, scanned and verified via direct company communications.
• Scientific meetings: more than 400 global conferences every year.
• Scientific literature: approximately 700 new biomedical and pharmaceutical literature references each week.
• Therapeutic patents: approximately 180 new patents abstracted and added to the database every week.
• Industry news: newswires and leading business sources scanned daily.
• Literature evaluations: an expert guide to drug literature that highlights key research papers and data.
• Current opinions: an expert opinion of the scientific and commercial significance of a paper or patent.
• Meeting reports: unique intelligence from meetings that highlights the most important disclosures.
• User Intelligence: comments to IDdb reports added confidentially by intranet-based users.
  

• Drug Reports. Records are updated continuously as new information is published. Comments from experts are also added in the form of literature evaluations, providing a professional opinion about the significance of a drug.
• Company Reports. These contain comprehensive company profiles and include information on licensing agreements, financial data, and graphs summarizing each company's R&D portfolio. You can link from R&D portfolio graphs to the underlying IDdb drug and patent reports, giving you a quick and easy overview of a competitor's R&D activities.
• Meeting Reports. Specially commissioned reports from a wide range of global meetings ensure you remain fully informed of the latest developments in your field.
• Patent Reports. These summarize the patent document, often including a searchable sample structure. Reports are generally available within two to three weeks of publication and often contain links to the full text of the original patent.
• Reference Reports. These comprise a full list of references from a diverse range of commercial and scientific sources. The reports can be sorted by author, date, or type of report.